Diebold Nixdorf Inc

DBD is in a Stage 2 advance within a sustained long-term uptrend, supported by an active Lockout Rally and Higher Highs & Higher Lows patterns. Price is currently pulling back into the rising 9/21 EMA zone, holding support on subdued volume and obeying the Lockout Rally dynamics despite overbought readings. Medium-term conditions favor continuation participation on pullbacks into this structural support range, justifying immediate buy-side engagement.

• ↑Q2 2026 revenue guidance $922.6M (+0.8% YoY) with $790M backlog
• ↑Q2 EPS expected at $1.10 (+83% YoY); product orders up 36%
• ↓Weak profitability factors highlight margin conversion challenges